Login / Signup

Treatment satisfaction with Omnipod DASH in adults with type 1 diabetes: A non-blinded 1:1 randomized controlled trial.

Yee Wen KongCheng Yi YuanKaterina KiburgKatrin BrownSteven TrawleyAndi PartoviKerryn RoemCecilia PhamNatalie HarrisonSpiros FourlanosElif I EkinciDavid Norman O'Neal
Published in: The Journal of clinical endocrinology and metabolism (2024)
Omnipod DASH System resulted in greater treatment satisfaction at 12 weeks in adults with type 1 diabetes using SMBG which was sustained after 24 weeks of device use without compromising sleep quality and fear of hypoglycemia. Improvements in glycemia were also observed.
Keyphrases
  • sleep quality
  • randomized controlled trial
  • type diabetes
  • depressive symptoms
  • clinical trial
  • systematic review
  • physical activity
  • metabolic syndrome
  • combination therapy
  • skeletal muscle
  • gestational age
  • meta analyses